Placental Expression of Indoleamine 2,3-dioxygenase

Overview

Journal Wien Med Wochenschr

Specialty General Medicine

Date 2012 Jun 22

PMID 22717876

Citations 6

Authors

Peter Sedlmayr

Astrid Blaschitz

Affiliations

Soon will be listed here.

Abstract

This review focuses on the placental expression of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase-1 (IDO1) and its potential roles, which may not only encompass immunosuppression and antimicrobial activity, but also vasodilation based on the endothelial expression on both sides of the feto-maternal interface.

Citing Articles

COVID-19. Biology, pathophysiology, and immunology: a pathologist view.

Chilosi M, Doglioni C, Ravaglia C, Piciucchi S, Dubini A, Stefanizzi L Pathologica. 2023; 115(5):248-256.

PMID: 38054899 PMC: 10699332. DOI: 10.32074/1591-951X-954.

Bioinformatics Analysis Identifies Potential Related Genes in the Pathogenesis of Intrauterine Fetal Growth Retardation.

Xiao C, Wang Y, Fan Y Evol Bioinform Online. 2022; 18:11769343221112780.

PMID: 35923419 PMC: 9340335. DOI: 10.1177/11769343221112780.

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface.

Kudo Y, Koh I, Sugimoto J Int J Tryptophan Res. 2021; 13:1178646920984163.

PMID: 33447047 PMC: 7780199. DOI: 10.1177/1178646920984163.

The Role of B7 Family Molecules in Maternal-Fetal Immunity.

Zhao Y, Zheng Q, Jin L Front Immunol. 2020; 11:458.

PMID: 32265918 PMC: 7105612. DOI: 10.3389/fimmu.2020.00458.

The therapeutic potential of targeting tryptophan catabolism in cancer.

Opitz C, Somarribas Patterson L, Mohapatra S, Dewi D, Sadik A, Platten M Br J Cancer. 2019; 122(1):30-44.

PMID: 31819194 PMC: 6964670. DOI: 10.1038/s41416-019-0664-6.

References

Lande R, Gilliet M . Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann N Y Acad Sci. 2010; 1183:89-103. DOI: 10.1111/j.1749-6632.2009.05152.x. View

Pallotta M, Orabona C, Volpi C, Vacca C, Belladonna M, Bianchi R . Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011; 12(9):870-8. DOI: 10.1038/ni.2077. View

Fleckner J, Martensen P, Tolstrup A, KJELDGAARD N, Justesen J . Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine. 1995; 7(1):70-7. DOI: 10.1006/cyto.1995.1009. View

Nelson J . Your cells are my cells. Sci Am. 2008; 298(2):64-71. View

Kudo Y, Hara T, Katsuki T, Toyofuku A, Katsura Y, Takikawa O . Mechanisms regulating the expression of indoleamine 2,3-dioxygenase during decidualization of human endometrium. Hum Reprod. 2004; 19(5):1222-30. DOI: 10.1093/humrep/deh218. View

Fallarino F, Grohmann U . Using an ancient tool for igniting and propagating immune tolerance: IDO as an inducer and amplifier of regulatory T cell functions. Curr Med Chem. 2011; 18(15):2215-21. DOI: 10.2174/092986711795656027. View

Kamimura S, Eguchi K, Yonezawa M, SEKIBA K . Localization and developmental change of indoleamine 2,3-dioxygenase activity in the human placenta. Acta Med Okayama. 1991; 45(3):135-9. DOI: 10.18926/AMO/32206. View

Heitger A . Regulation of expression and function of IDO in human dendritic cells. Curr Med Chem. 2011; 18(15):2222-33. DOI: 10.2174/092986711795656018. View

Nelson J, Gillespie K, Lambert N, Stevens A, Loubiere L, Rutledge J . Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A. 2007; 104(5):1637-42. PMC: 1785262. DOI: 10.1073/pnas.0606169104. View

10.

Kudo Y, Boyd C, Sargent I, Redman C . Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. Am J Obstet Gynecol. 2003; 188(3):719-26. DOI: 10.1067/mob.2003.156. View

11.

Yamazaki F, Kuroiwa T, Takikawa O, Kido R . Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme. Biochem J. 1985; 230(3):635-8. PMC: 1152665. DOI: 10.1042/bj2300635. View

12.

Sedlmayr P, Kroneis T . Verification of the genomic identity of candidate microchimeric cells. Chimerism. 2011; 2(3):63-4. PMC: 3234356. DOI: 10.4161/chim.2.3.17741. View

13.

Huang L, Baban B, Johnson 3rd B, Mellor A . Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege. Int Rev Immunol. 2010; 29(2):133-55. PMC: 3671384. DOI: 10.3109/08830180903349669. View

14.

Aluvihare V, Kallikourdis M, Betz A . Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004; 5(3):266-71. DOI: 10.1038/ni1037. View

15.

Sono M, Roach M, Coulter E, Dawson J . Heme-Containing Oxygenases. Chem Rev. 1996; 96(7):2841-2888. DOI: 10.1021/cr9500500. View

16.

Takikawa O, Kuroiwa T, Yamazaki F, Kido R . Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem. 1988; 263(4):2041-8. View

17.

Chaves A, Ceravolo I, Gomes J, Zani C, Romanha A, Gazzinelli R . IL-4 and IL-13 regulate the induction of indoleamine 2,3-dioxygenase activity and the control of Toxoplasma gondii replication in human fibroblasts activated with IFN-gamma. Eur J Immunol. 2001; 31(2):333-44. DOI: 10.1002/1521-4141(200102)31:2<333::aid-immu333>3.0.co;2-x. View

18.

Carlin J, Borden E, Sondel P, Byrne G . Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leukoc Biol. 1989; 45(1):29-34. DOI: 10.1002/jlb.45.1.29. View

19.

Blaschitz A, Gauster M, Fuchs D, Lang I, Maschke P, Ulrich D . Vascular endothelial expression of indoleamine 2,3-dioxygenase 1 forms a positive gradient towards the feto-maternal interface. PLoS One. 2011; 6(7):e21774. PMC: 3130744. DOI: 10.1371/journal.pone.0021774. View

20.

Kudo Y, Boyd C, Spyropoulou I, Redman C, Takikawa O, Katsuki T . Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta. J Reprod Immunol. 2004; 61(2):87-98. DOI: 10.1016/j.jri.2003.11.004. View